This statistic shows the earnings per Biogen share from 2014 to 2024. According to the company's report, diluted earnings per share increased from around eight U.S. dollars in 2023 to 11.2 dollars in 2024. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Biogen, & U.S. Securities and Exchange Commission. (February 14, 2025). Earnings per share of Biogen from 2014 to 2024 (in U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 16, 2026, from /statistics/968222/earnings-per-share-biogen/
Biogen, und U.S. Securities and Exchange Commission. "Earnings per share of Biogen from 2014 to 2024 (in U.S. dollars)." Chart. February 14, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 16, 2026. /statistics/968222/earnings-per-share-biogen/
Biogen, U.S. Securities and Exchange Commission. (2025). Earnings per share of Biogen from 2014 to 2024 (in U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 16, 2026. /statistics/968222/earnings-per-share-biogen/
Biogen, and U.S. Securities and Exchange Commission. "Earnings per Share of Biogen from 2014 to 2024 (in U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 Feb 2025, /statistics/968222/earnings-per-share-biogen/
Biogen & U.S. Securities and Exchange Commission, Earnings per share of Biogen from 2014 to 2024 (in U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/968222/earnings-per-share-biogen/ (last visited July 16, 2026)
Earnings per share of Biogen from 2014 to 2024 (in U.S. dollars) [Graph], Biogen, & U.S. Securities and Exchange Commission, February 14, 2025. [Online]. Available: /statistics/968222/earnings-per-share-biogen/
